Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Naproxen
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Naproxen 500mg tablets
1001010P0AAAEAE
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 796,014 |
|
Naproxen 250mg tablets
1001010P0AAADAD
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 290,957 |
|
Naproxen 500mg gastro-resistant tablets
1001010P0AAAIAI
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 95,864 |
|
Naproxen 250mg gastro-resistant tablets
1001010P0AAAHAH
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 55,579 |
|
Naproxen 500mg / Esomeprazole 20mg modified-release tablets
1001010P0AABBBB
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 7,550 |
|
Naproxen 375mg gastro-resistant tablets
1001010P0AAAJAJ
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 1,996 |
|
Naproxen 250mg/5ml oral suspension
1001010P0AABFBF
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 1,153 |
|
Naproxen 250mg effervescent tablets sugar free
1001010P0AABDBD
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 887 |
|
Vimovo 500mg/20mg modified-release tablets
1001010P0BUAABB
|
Vimovo | Naproxen | Musculoskeletal and Joint Diseases | 488 |
|
Naprosyn 500mg tablets
1001010P0BCABAE
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | 395 |
|
Naprosyn EC 500mg tablets
1001010P0BCAIAI
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | 299 |
|
Naprosyn 250mg tablets
1001010P0BCAAAD
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | 280 |
|
Naprosyn EC 250mg tablets
1001010P0BCAGAH
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | 254 |
|
Naproxen 125mg/5ml oral suspension sugar free
1001010P0AABEBE
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 233 |
|
Naprosyn EC 375mg tablets
1001010P0BCAHAJ
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | 146 |
|
Period Pain Reliever 250mg gastro-resistant tablets
1001010P0BZAAAH
|
Accord (Naproxen) | Naproxen | Musculoskeletal and Joint Diseases | 74 |
|
Naproxen 200mg/5ml oral suspension
1001010P0AABCBC
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 27 |
|
Stirlescent 250mg effervescent tablets
1001010P0BXAABD
|
Stirlescent | Naproxen | Musculoskeletal and Joint Diseases | 17 |
|
Naproxen 125mg/5ml oral suspension
1001010P0AAARAR
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 13 |
|
Arthrosin 250 tablets
1001010P0BDACAD
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin 500 tablets
1001010P0BDADAE
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin EC 250 tablets
1001010P0BDAFAH
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin EC 500 tablets
1001010P0BDAEAI
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Boots Period Pain Reliever 250mg gastro-resistant tablets
1001010P0BWAAAH
|
Boots (Naproxen) | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Feminax Ultra 250mg gastro-resistant tablets
1001010P0BSAAAH
|
Feminax Ultra | Naproxen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.